Clinical Trial Update: IC14 for Treatment of Amyotrophic Lateral Sclerosis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of IC14 for amyotrophic lateral sclerosis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis
• Motor Neuron Disease

Drugs mentioned

• IC14

Snippet

Sponsor: Implicit Bioscience | Conditions: Amyotrophic Lateral Sclerosis, Motor Neuron Disease | Phase 2 | Status: WITHDRAWN